205 related articles for article (PubMed ID: 35368700)
21. [Bioinformatics analysis of COL1A1 regulated by miR-129-5p as a potential therapeutic target for gastric cancer].
Yang W; Pan Y; Guan P; Li X; You C
Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):540-546. PubMed ID: 31140417
[TBL] [Abstract][Full Text] [Related]
22. Could CTSK and COL4A2 be specific biomarkers of poor prognosis for patients with gastric cancer in Asia?-a microarray analysis based on regional population.
Feng Z; Qiao R; Ren Z; Hou X; Feng J; He X; Chen D
J Gastrointest Oncol; 2020 Apr; 11(2):386-401. PubMed ID: 32399279
[TBL] [Abstract][Full Text] [Related]
23. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
24. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
Li D; Yin Y; He M; Wang J
Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
[TBL] [Abstract][Full Text] [Related]
25. Identification of potential key genes in gastric cancer using bioinformatics analysis.
Wang W; He Y; Zhao Q; Zhao X; Li Z
Biomed Rep; 2020 Apr; 12(4):178-192. PubMed ID: 32190306
[TBL] [Abstract][Full Text] [Related]
26. Screening key genes and biomarkers in gastrointestinal metaplasia that progress to gastric cancer by integrated bioinformatics analysis.
Pang L; Yan X; Su D
J Physiol Pharmacol; 2021 Dec; 72(6):. PubMed ID: 35485356
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatics Analysis of Hub Genes and Potential Therapeutic Agents Associated with Gastric Cancer.
Zhang S; Xiang X; Liu L; Yang H; Cen D; Tang G
Cancer Manag Res; 2021; 13():8929-8951. PubMed ID: 34876855
[TBL] [Abstract][Full Text] [Related]
28. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
29. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
Lin Y; Zhang L; Zhang X; Wei X; Liu X; Xie Y; Han G
J Environ Pathol Toxicol Oncol; 2023; 42(4):61-68. PubMed ID: 37522568
[TBL] [Abstract][Full Text] [Related]
30. Identification of key genes with prognostic value in gastric cancer by bioinformatics analysis.
Wang R; Chen X; Huang C; Yang X; He H; OuYang C; Li H; Guo J; Yang C; Lin Z
Front Genet; 2022; 13():958213. PubMed ID: 36110205
[No Abstract] [Full Text] [Related]
31. High expression of ghrelin and obestatin prepropeptide in tumor tissues predicted adverse overall survival in gastric carcinoma patients.
Wu X; Wu Y; Ye B; Wu F; Wang P
Medicine (Baltimore); 2020 Jun; 99(26):e20635. PubMed ID: 32590738
[TBL] [Abstract][Full Text] [Related]
32. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
[TBL] [Abstract][Full Text] [Related]
33. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
[TBL] [Abstract][Full Text] [Related]
34. Identification of core genes and outcome in gastric cancer using bioinformatics analysis.
Sun C; Yuan Q; Wu D; Meng X; Wang B
Oncotarget; 2017 Sep; 8(41):70271-70280. PubMed ID: 29050278
[TBL] [Abstract][Full Text] [Related]
35. Aurora Kinase A as a Diagnostic and Prognostic Marker of Malignant Mesothelioma.
Guo Z; Shen L; Li N; Wu X; Wang C; Gu Z; Chen Z; Liu J; Mao W; Han Y
Front Oncol; 2021; 11():789244. PubMed ID: 34956905
[TBL] [Abstract][Full Text] [Related]
36. Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer.
Chen PF; Wang F; Nie JY; Feng JR; Liu J; Zhou R; Wang HL; Zhao Q
Onco Targets Ther; 2018; 11():6425-6436. PubMed ID: 30323620
[TBL] [Abstract][Full Text] [Related]
37. Key Genes Associated with Prognosis and Tumor Infiltrating Immune Cells in Gastric Cancer Patients Identified by Cross-Database Analysis.
Zhang T; Wang BF; Wang XY; Xiang L; Zheng P; Li HY; Tao PX; Wang DF; Gu BH; Chen H
Cancer Biother Radiopharm; 2020 Nov; 35(9):696-710. PubMed ID: 32401038
[No Abstract] [Full Text] [Related]
38. Differentially expressed genes
Jiang K; Liu H; Xie D; Xiao Q
Oncol Lett; 2019 Mar; 17(3):3191-3202. PubMed ID: 30867749
[TBL] [Abstract][Full Text] [Related]
39. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
Hammad A; Elshaer M; Tang X
Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
[TBL] [Abstract][Full Text] [Related]
40. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
Zhao X; Wu S; Jing J
Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
